Conray 30

   
Google
 
Web NewDrugInformation.com

Conray 30


Drug - Conray 30
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Iothalamate Meglumine
Multiple ingredients are in alphabetical order.

Strength - 30%
The potency of the active ingredient(s), Iothalamate Meglumine. May repeat for multiple part products.

Applicant - MALLINCKRODT
The firm name holding legal responsibility for Conray 30. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 016983
The FDA assigned number to Conray 30. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Conray 30. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Conray 30 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Conray 30. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Conray 30 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Mallinckrodt Medical Inc
The full name of the firm holding legal responsibility for the new application of Conray 30.

Conray 30